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INTRoduCTIoN
  Locoregionally advanced head and neck 
cancers are optimally treated with definitive con-
current chemoradiotherapy or surgical resection 
followed by radiotherapy with or without chemo-
therapy  (1).    Despite  aggressive  local  treatment, 
approximately 20-36% of patients will experience 
locoregional recurrence within 3-5 years, represent-
ing 50-67% of all recurrences (1-3).  In patients who 
experience disease recurrence within a previously 
irradiated field, aggressive salvage surgical resec-
tion is the preferred intervention (4).  Previously 
reported series of surgical salvage have generally 
included patients treated with suboptimal primary 
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AbSTRACT - Background: Primary management of advanced head/neck cancers 
involves  concurrent chemoradiotherapy .  Subsequently, regional and local failures 
are managed with resection but there have been few reports that describe the mor-
bidity and disease control outcomes of surgical salvage in this setting. Methods: 
Retrospective analysis describes complications, survival, and patterns of failure af-
ter salvage resection of isolated local and/or regional failures of head/neck cancer 
following definitive concurrent chemoradiotherapy. Results: Sixteen patients were 
identified for inclusion: laryngectomy in 11 patients, oral cavity/oropharynx resec-
tion in 2 patients, and neck dissection alone in 4 patients.  Ten patients required 
graft tissue reconstruction (6 pedicle and 4 free flap).  Median post-operative hospi-
talization was 7 days (range 3-19), and 4 patients required hospital re-admission.  At 
a median survivor follow-up of 15.8 months (range 4.3-34.9), 10 patients were alive 
(6 without evidence of disease).  Seven patients experienced disease recurrence 
at a median 6.7 months (range 0-12.6) following salvage resection (2 with isolated 
distant failures).  Estimated 2-year local/regional control, freedom from failure, and 
overall survival were 58%, 39%, and 58%, respectively. Conclusions: Surgical sal-
vage after primary definitive concurrent chemoradiotherapy is feasible with toxicity 
and outcomes similar to prior radiotherapy alone or sequential chemotherapy and 
radiation.  Local andregional recurrence remains the predominant pattern of failure.
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of unknown cause.”  Freedom from failure was 
measured from date of salvage resection to date 
of second recurrence (earliest sign of clinical, ra-
diographic, or pathologic disease) or last follow-up 
if there was no evidence of disease recurrence.  A 
patient was considered to have died of treatment-
associated toxicity if there was clear association 
between toxicity and death or if the patient died 
during or within 30 days of hospitalization attributed 
to treatment toxicity (without other evident cause).   
Treatment-associated mortality was considered an 
event for freedom from failure.  If a patient died of 
unclear cause, but was known to have had recur-
rent disease prior to death, he/she was considered 
to have died of  disease.  Patterns of failure were 
recorded by initial site(s) of disease recurrence.  
Literature Review Search Criteria
  An Ovid Medline search was performed       
using the search terms “head and neck neo-
plasms,” “local neoplasm recurrence,” “recurrence,” 
and    “resection.”  Articles were searched for post-
chemoradiotherapy  salvage  resection-specific           
experiences.  A secondary search wasperformed 
by  reviewing    references  from  articles  identified 
from the search. 
Statistical Analysis
  The Kaplan-Meier method was used to cal-
culate estimated locoregional control, freedom from 
failure, and overall survival for the entire cohort.   
Proportionality was tested for each covariate of in-
terest.  Those that failed were either not included or 
were reparameterized to adhere to the proportion-
ality assumption.  Cox regression was used to esti-
mate the hazard ratio (HR) comparing risk of time-
to-event outcomes by covariates.   Disease control 
estimation, survival estimation, and univariate anal-
yses were performed using R version 2.6.1 (The R 
Core Development Team; http://www.r-project.org).   
RESuLTS
  Between  September  2001  and  Octo-
ber  2007,  136  patients  initiated  platinum-based                   
concurrent chemoradiotherapy for locoregion-
ally advanced head/neck cancer.  Isolated head/
neck recurrence developed as the initial site of 
failure in 28 patients (20.6%) at a median survivor 
follow-up of 33.1 months (range 4.6-71.1).  17 pa-
tients       underwent surgical resection as initial 
salvage intervention; however, one patient had no 
evidence of invasive disease at salvage resection 
(post-treatment  biopsy  at  5.5  weeks  post-treat-
ment    completion had demonstrated residual dis-
ease).  This patient was included in assessment 
of    complications but excluded from the survival 
and patterns of failure analyses.  Patient, tumor, 
and staging characteristics are shown in Table 1.   
All patients had been prescribed to a dose of 66-
70 Gy, and all but one completed the prescribed 
course of therapy.  Excluding this patient, the medi-
an initial chemoradiotherapy duration was 50 days 
(range  43-63),  with  one  patient  requiring  a  one-
week  treatment  break  (63  total  treatment  days).   
All but one    patient had pathologic stage III-IV 
recurrent disease (Table 2) at salvation resection.   
The primary tumor adverse pathologic features of 
lymphovascular invasion and perineural invasion 
were identified in 3 and 4 cases, respectively, and 
4 patients had microscopically involved margins at 
Head/Neck Neoplasms 2011 30 Vol. 13 No. 2 Head/Neck Neoplasms
therapy (radiotherapy alone or sequential chemo-
therapy and radiotherapy), while subsequent ran-
domized trials (5-8) and a meta-analysis (9) have 
demonstrated superior locoregional control and 
survival for concurrent chemoradiotherapy over ra-
diotherapy alone or sequential chemoradiotherapy 
(5), albeit associated with increased risk of adverse 
effects (5).  Few studies have evaluated the compli-
cations and outcomes of surgical salvage of locore-
gional failures following modern platinum-based 
concurrent chemoradiotherapy (10-13).
  The present study is a retrospective analy-
sis of complications, disease control, patterns of 
failure, and survival in a cohort of patients treated 
with salvage surgical resection at the Medical Uni-
versity of South Carolina (MUSC).  
 
METHodS 
Ethical Considerations
  Following Institutional Review Board ap-
proval at MUSC, a research spreadsheet was cre-
ated with study-specific patient, treatment, and out-
come data fields.  Non-protected health information   
remained within the primary sources (departmental 
chart, quality assurance database(s), and/or elec-
tronic medical record system).  
Selection Criteria
  Eligible cases were identified by review of 
the radiation oncology departmental quality assur-
ance database and office management software.   
The database contained all patients at MUSC that 
were  initiated  on  definitive  chemoradiotherapy; 
eligible cases were identified within the database 
by searching for head and neck cancer patients.   
Surgical  salvage  was  defined  as  curative-intent 
resection for residual disease or recurrent primary 
tumor, nodal disease, and/or second primary tumor 
within an irradiated field following platinum-based 
concurrent chemoradiotherapy.  Primary definitive 
chemoradiotherapy and salvage resection and re-
construction (when necessary) were performed at 
MUSC in all cases.  Exclusion criteria for this study 
included primary chemoradiotherapy at an outside 
institution, evidence of distant metastatic disease 
at the time of surgical salvage and/or post-salvage 
follow-up of less than 3 months (unless evidence of 
disease progression/recurrence and/or death).  All 
patients included in descriptive outcomes analysis 
were required to have had pathologic proof of squa-
mous cell carcinoma recurrence.
Patient Work-Up and Management
  All patients were initially evaluated at the 
MUSC Hollings Cancer Center multidisciplinary 
head and neck oncology clinic, with evaluations 
by surgical, medical, and radiation oncology phy-
sicians, as well as speech therapy and dental on-
cology/maxillofacial-prosthedontic  specialists  as 
indicated.  Following complete metastatic workup, 
which consisted of  chest computed tomography 
(CT)  and/or  positron  emission  tomography  (PET 
or PET/CT), patients were offered surgical salvage 
based on feasibility surgical resection and/or pa-
tients’ medical operability.  When microvascular 
“free flap” reconstruction was required, peripheral 
vascular studies were performed in order to identify 
viable graft tissue harvest sites.  
  Surgical intervention was left to the discre-
tion of the treating head/neck surgeon and recon-
struction specialist.  All patients underwent at least 
selective neck dissection at the time of salvage re-
section and more aggressive intervention  in cases 
where there was neck recurrence (particularly with 
radiographic and/or clinical evidence of extranodal 
extension).  When reconstruction was indicated, 
rotational  flaps  were  constructed  from  pectoralis 
major and free flaps were harvested from anterior 
thigh, radial forearm, or fibula sites.  
  Following completion of treatment, patients 
were assessed at a minimum of every 3 months for 
2 years, then every 6 months for 3 years, and annu-
ally thereafter.  Surveillance fiberoptic endoscopy 
was performed routinely during follow-up appoint-
ments.  A neck CT or MRI was generally performed 
2-3 months following salvage resection, then again 
6 months later and/or as indicated based upon clini-
cal suspicion.  During the follow-up period, meta-
static surveillance with chest X-ray and/or chest CT 
was generally performed once within 6 months of 
salvage, then repeated in situations of clinical sus-
picion or at time of locoregional recurrence.
Endpoints and Definitions
  The principal outcome measure of this 
study was overall survival which was measured 
from date of salvage resection to last follow-up or 
death.  Secondary outcome measures included 
duration of post-salvage hospitalization, post-oper-
ative complication rates, pattern of failure, locore-
gional freedom from failure, and overall freedom 
from failure.  Patient status at last follow-up was 
recorded as “alive, no evidence of disease,” “alive 
with disease,” “died of  disease,” “died of treatment-
associated toxicity,” “died of other cause,” or “died 
Salvage Cohort
(n=16*)
Salvage Cohort
(n=16*)
Salvage Cohort
(n=16*)
n %
Age
Median
(Range)
>60 yrs
59 yrs
(46-80)
8 50
Gender
Male 12 75
Race
White 10 62
Initial Disease Site
Oropharynx
Larynx
Hypopharynx
5
10
1
31
62
6
Interval Since Definitive 
ChemoRT# Completion
Median
(Range)
7.6 months
(1.6-27.6)
Prior RT Characteristics
Median Dose
(Dose Range)
7000 cGy
(4800-7000)
Relation to Prior RT Field
In-Field
Field Margin
  14
2
88
12
Recurrent Tumor Site
Primary 
Second Primary
Irradiated Neck
10
1
5
62
6
31
Chest Staging at Recurrence
None$
Chest Radiograph
Chest CT &/or PET
1
5
10
6
31
62
Table 1:  Patient, Tumor, and Staging Characteristics 
*Excludes one patient without evidence of residual carcinoma 
at salvage resection.  #ChemoRT=Cisplatin-based concurrent 
chemoradiotherapy.  $This patient survived >5 years without 
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survival are demonstrated in Table 3.  Despite the 
limitation of small sample size, the pathologic nodal 
stage and presence of extracapsular carcinoma 
within the soft tissue of the neck were associated 
with  significantly  decreased  rates  of  locoregional 
control and freedom from disease failure.  The as-
sociation of these factors with overall survival was 
not demonstrated at a statistically significant level; 
however, there was a trend toward worse survival 
for patients with metastatic carcinoma within neck 
soft tissue. 
   Toxicities, local control, and survival out-
comes from the present study are pooled with other 
published series of surgical salvage following con-
current chemoradiotherapy in Table 4.  
dISCuSSIoN
  The role of surgical resection in locoregion-
ally advanced head/neck cancer has evolved over 
time.  Modern platinum-based concurrent chemo-
radiotherapy yields equivalent disease control, and 
is the preferred primary therapy when functional 
organ  preservation  is  feasible  (14).    Despite  ag-
post-salvage (range 0-12.6), involving 1 completely 
resected primary site, 1 incompletely resected pri-
mary site, 2 dissected necks, 1 resected primary 
and dissected neck, and 2 isolated distant failures.   
Secondary salvage interventions included chemo-
therapy in 2 patients, concurrent chemotherapy and 
re-irradiation in 1 patient, re-resection in 1 patient, 
and supportive care for 3 patients.  The estimated 
median overall freedom from failure for the study 
group was 10.8 months, while the median overall 
survival had not yet been reached (and was thus 
inestimable).  The estimated 1- and 2-year locore-
gional control were both 58.0% (95% confidence 
interval: 35.4%-95.2%), as demonstrated in Figure 
1.  The estimated 1- and 2-year overall freedom 
from failure were 46.9% (27.0%-81.4%) and 39.1% 
(20.2%-75.4%), respectively (Figure 2).  The esti-
mated 1- and 2-year overall survivals were 78.7% 
(59.7%-100%) and 58.3% (35.1%-97.0%), respec-
tively (Figure 3).  
  Univariate analyses of patient-, tumor-, and 
treatment-related factor associations with locore-
gional control, freedom from failure, and overall 
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salvage resection.  Extranodal extension within the 
neck was documented in 5 cases.
  Salvage surgical intervention involved total 
laryngectomy in 8 patients, total laryngopharyngec-
tomy in 1 patient, supracricoid laryngectomy in 2 
patients,  oral  cavity/oropharyngeal  composite  re-
section in 2 patients, and neck dissection alone in 
4 patients.  All patients’ necks were surgically ad-
dressed at salvage, involving unilateral selective 
dissection in 5 patients, unilateral modified radical 
neck dissection in 2 patients, unilateral radical neck 
dissection in 1 patient, bilateral selective neck dis-
sections in 6 patients, and bilateral modified radical 
neck dissections in 3 patients.  10 patients required 
flap reconstruction (6 pedicle and 4 free).  
  The median post-operative hospitalization 
was 7 days (range 3-19), with significant complica-
tions of hematoma (4), wound breakdown (3), and 
fistula (1). 4 patients required a median duration 13 
day (range 4-30) hospital re-admission following ini-
tial dischargeReasons for re-hospitalization includ-
ed pharyngocutaneous fistula, wound breakdown, 
neck abscess, and bleeding at the gastrostomy site 
(associated with supratherapeutic anticoagulation). 
One patient received immediate post-salvage che-
motherapy and one concurrent chemoradiotherapy 
for adverse pathologic features (surgical margin 
and extranodal neck disease, respectively).  2 out of 
10 patients who underwent graft tissue reconstruc-
tion at the time of salvage developed complications 
requiring intervention.  One patient developed ne-
crosis along the distal margin of a rotational pec-
toralis flap, requiring takedown and reconstruction 
using a second pedicle flap.  No further complica-
tions were observed.  Another patient experienced 
delayed would dehiscence of a free flap reconstruc-
tion, with pharyngocutaneous fistula formation ap-
proximately 2 months post-salvage/reconstruction.   
The flap was removed and the defect was recon-
structed with a rotational pectoralis flap, resulting in 
no  further complication.
  Two patients  died of treatment-associated 
complications.  One patient underwent salvage bi-
lateral modified radical neck dissections for failure 
within an irradiated neck (4 months after completion 
of chemoradiotherapy for cT4aN2cM0 hypopha-
ryngeal cancer originating at the pyriform sinus).   
Recurrent disease in the neck was significant for 
extension into the soft tissues of the neck as well 
as perineural and lymphovascular space invasion.   
The post-operative course was complicated by a 
neck hematoma requiring evacuation and an oro-
cutaneous fistula, with a salivary leak.  The patient 
was ultimately discharged 10 days after salvage re-
section but died 3 days later of unspecified cause.   
Another patient required surgical salvage for resid-
ual/progressive primary tumor 10 weeks following 
concurrent chemoradiotherapy (initial cT3N0 oro-
pharyngeal cancer).  Following salvage palatecto-
my with inferior maxillectomy and partial glossecto-
my with anterolateral thigh free flap reconstruction 
and bilateral selective neck dissections, the patient 
experienced bleeding from the oronasal and neck 
incisions.  These complications resolved following 
discontinuation of heparin, after which the patient 
was discharged (8 days post-salvage).  The patient 
died later that day of an unspecified cause.
  At  a  median  survivor  follow-up  of  15.8 
months (range 4.3-34.9) post-salvage, 10 patients 
were alive (6 without evidence of disease) and 6 
patients had died (3 of disease, 2 of intervention, 
and 1 of unknown cause ).  Seven patients experi-
enced disease recurrence at a median 6.7 months 
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  pT0/Tx pT1 pT2 pT3 pT4a pT4b
pN0 4 1 3 1
pN1 3
pN2a
pN2b
pN2c 1 1
pN3 2
Table 2:  Recurrent Tumor Stage Characteristics.
Figure 1: Locoregional control for salvage resection population.   
Fourteen patients at risk due to subtraction of two patients who 
died of treatment-associated toxicity within two weeks of salvage 
resection.
Factor
Locoregional 
Control
Locoregional 
Control
Freedom From 
Failure
Freedom From 
Failure Overall Survival Overall Survival
Factor
HR p HR p HR p
Gender 1.420 0.75 1.350 0.87 1.520 0.71
Race 0.865 0.87 0.396 0.25 0.280 0.26
Age 0.910 0.13 0.954 0.23 1.010 0.88
Active Tobacco Use 1.790 0.56 0.601 0.53 0.360 0.36
Time to Recurrence 1.090 0.098 1.030 0.38 0.894 0.22
rcT-Stage 1.000 0.99 0.883 0.45 0.852 0.47
rcN-Stage 1.480 0.056 1.360 0.058 1.120 0.62
rcAJCC Stage 1.660 0.27 1.570 0.2 1.080 0.87
rpT-Stage 0.953 0.81 1.050 0.71 0.847 0.45
rpN-Stage 1.940 0.024 1.700 0.012 1.370 0.19
rpAJCC Stage 2.830 0.086 2.200 0.083 1.420 0.57
Margin at Salvage 4.670 0.094 3.260 0.097 1.750 0.54
Lymphovascular 
Invasion
1.860 0.54 1.850 0.46 0.972 0.98
Perineural Invasion 2.280 0.51 2.460 0.31 1.380 0.73
Metastatic Carcinoma in 
Neck Soft Tissue 12.000 0.034 8.300 0.013 4.960 0.088
Table 3: Univariate Analysis of Factors Associated with Study Endpoints.34 35 Vol. 13 No. 2
gressive combined-modality therapy, approximate-
ly 20-36% of patients still experience locoregional 
recurrence within 3-5 years, representing approxi-
mately half of all recurrences (1).  In patients who 
experience disease recurrence within a previously 
irradiated field, aggressive salvage surgical resec-
tion is the preferred intervention, yielding 55% lo-
cal control and 32-39% survival at 5 years (4,15).   
These have primarily included patients treated with 
radiotherapy alone or sequential radiotherapy and 
chemotherapy, which have demonstrated inferior 
disease control when compared with concurrent 
chemoradiotherapy (5-10).  
  Few reports have focused on the compli-
cations, disease control, and survival outcomes 
for concurrent chemoradiotherapy patients.  The 
RTOG 91-11 study provides the best comparative 
data for salvage resection in the setting of radio-
therapy  alone  versus  sequential  chemotherapy/
studies (disease site, reconstruction techniques) 
and inconsistent scoring of self-limited or “minor” 
fistulae in the retrospective analyses relative to the 
RTOG 91-11 analysis.  If only “major” fistulae are 
considered for the RTOG study, the rate (11%) is 
more consistent with the retrospective series.  With-
in our own series, 2 of the 3 fistulae were self-limited 
salivary gland leaks which resolved with conserva-
tive measures.  Thus, the overall risk of significant 
fistula formation after surgical salvage for concur-
rent chemoradiotherapy failures is approximately 
5-10%.    Graft  tissue  reconstruction  may  have  a 
beneficial  impact  on  reducing  these  major  com-
plications.  A single-institution analysis of salvage 
laryngectomy following radiotherapy or chemora-
diotherapy demonstrated a reduced risk of fistula 
for free flap reconstruction compared with primary 
closure (18% versus 50%, p=0.08) (16).  Similarly, 
the risk of stricture and feeding tube dependence 
was reduced with free flap reconstruction.  It should 
be noted that this analysis was restricted to patients 
whose disease was generally limited to the larynx, 
excluding patients for whom partial pharyngectomy 
or total laryngopharyngectomy would have been re-
quired.  Within the present study population, com-
plications were similar regardless of graft tissue re-
construction (4 of 11 reconstructed patients versus 
2 of 6 primary closure patients). 
  The present study demonstrated an esti-
mated 2-year overall survival of 58%, which is com-
parable to other single-institution series of post-
radiotherapy versus concurrent chemoradiotherapy 
(5).  Of 517 patients initially randomized, 129 re-
quired total laryngectomy (95% for recurrent/resid-
ual cancer) (10).  While pharyngocutaneous fistula 
formation was less common in the radiotherapy 
alone arm (15%) compared to the the concurrent 
chemoradiotherapy arm (30%), this did not reach 
statistical significance (p>0.05).  Similarly, the over-
all incidence of major and minor complications was 
not significantly different between treatment groups 
(52-59%).  These consisted mainly of fistulae for-
mation, infection, wound dehiscence, dysphagia 
and/or inability to take fluids, which are consistent 
with complications reported by other published se-
ries (10-12).  Within the RTOG concurrent chemo-
radiotherapy group, the rate of fistula was some-
what higher than that described in single-institution 
series (30% versus 5-8%) (10-12).  This may be 
associated with inherent differences between the 
chemoradiotherapy  salvage  resection  (11,13)  as 
well as mixed-treatment populations (4).  Patients 
with smaller tumor burden (rT1-2) appear to have im-
proved survival over larger tumors, as do laryngeal 
recurrences over pharyngeal sites (4,10,15,17,18).   
Within our own population, all 4 patients with long-
term disease-free and overall survivals (>2 years) 
were locoregional failures of larynx primary sites, 
despite locally advanced disease at recurrence (rp-
T4aN0 in two patients, rpT3N0 in one, and rpTxN1 
in one).  The interval from primary therapy comple-
tion to disease failure does not appear to impact 
disease control or survival outcomes (4).  Though 
limited by small numbers, no association was iden-
tifiable within the present study population.
  The role of immediate post-salvage che-
motherapy  and/or  re-irradiation  remains  to  be 
determined.  A recently published French trial 
randomized  130irradiated  patients  to  adjuvant 
chemoradiotherapy or observation following sal-
vage resection (19).  Despite improved local con-
trol and disease-free survival, no overall survival 
benefit was observed, and severe late toxicities (in-
cluding subcutaneous fibrosis, osteoradionecrosis, 
and trismus) were higher in the adjuvant chemo-
radiotherapy arm (39% vs 11% at 2 years).  It is 
possible that the benefit may be limited to a spe-
cific “high-risk” subset of patients requiring salvage 
resection.  One single-institution series of post-
chemoradiotherapy failures demonstrated a trend 
toward poorer survival in patients with the specific 
Head/Neck Neoplasms Head/Neck Neoplasms 2011
Series N
Methodol
ogy Site(s)
2y Local 
Control
2y 
Overall 
Survival
Major 
Complications
Richey11
(UNC, 2007) 38
Retrospect
ive 
Review
Multiple 42% 27%
Fistula (1/38)
Wound Dehiscence 
(2/38)
Respiratory Failure 
(2/38)
Sepsis (1/38)
Weber10
(RTOG 91-11, 
2003)
27 RCT Larynx 74% 71%
Fistula (8/27)
Wound Dehiscence 
(4/27)
Morgan12
(MDACC, 
2007)
38
Retrospect
ive 
Review
Multiple N/R N/R Fistula (3/38)
Infection (2/38)
Yom13
(Multi-
Institutional, 
2005)
14*
Retrospect
ive 
Review
Multiple 64%* 57%*
Wound Dehiscence 
(3/14)
Kearney
(MUSC)
17
Retrospect
ive 
Review
Multiple 58%# 58%#
Fistula (3/17)
Wound Dehiscence 
(3/17)
Flap Breakdown 
(2/10)
Table 4: Published Series of Toxicities and Outcomes for Salvage Resection of Concurrent Chemoradiotherapy Recurrences in Head/
Neck Cancer. 
*Twelve of fourteen underwent surgical salvage for residual or progressive disease noted at post-chemoradiotherapy assessment, local 
control and survival reflect crude recurrence rates rather than 2-year estimates.  #Survival data based upon 16 patients with pathologic 
disease at salvage, excludes one patient with squamous cell carcinoma at post-chemoradiotherapy biopsy but no evidence of disease 
following salvage laryngectomy.
Figure 2: Freedom from disease failure for salvage resection 
population.
Figure 3: Overall survival for salvage resection population.36 37 Vol. 13 No. 2
high-risk features of involved surgical margins and/
or  extranodal  neck  disease  (11).    Alternatively, 
these patients may simply have more advanced 
disease and would have a worse prognosis regard-
less of post-salvage intervention.  Within the pres-
ent study, two patients underwent immediate post-
salvage therapy for high-risk pathologic features.   
One patient received immediate chemotherapy for 
involved surgical margins and another underwent 
concurrent chemotherapy and re-irradiation for ex-
tranodal carcinoma within their previously irradiated 
neck.  Neither patient experienced significant post-
salvage complications; however, both experienced 
local disease failure within 6 months.   
  Despite aggressive surgical salvage, the 
majority of disease recurrences involve the primary 
tumor site.  Of 7 patients from the present series 
who  experienced  disease  recurrence,  5  recur-
rences  involved the tumor bed.  This is consistent 
with other published data (11); however, the pat-
tern of failure appears to shift toward more distant 
metastasis for advanced node-positive recurrences 
(11,13) and those treated with radiotherapy alone 
(10,20).  The timing of post-salvage disease failure 
was also consistent with previously published se-
ries (median 9 months) (11,18); all but one patient 
within the present series failed within one year (iso-
lated distant failure at 12.6 months).  As suggested 
by Goodwin’s comprehensive review (4), the rapidi-
ty of post-salvage recurrence may be attributable to 
advanced stage at initial recurrence presentation.   
Specifically, the analysis demonstrated an inverse 
relationship between recurrent disease stage and 
post-salvage median disease-free survival (>22.1, 
>11.5, 14.4, and 5.5 months for stages I, II, III, and 
IV disease, respectively).  Within the present se-
ries, all patients who experienced post-salvage dis-
ease failure had recurrent pathologic stage III (n=2) 
or IV (5) disease.
  Salvage resection of local and/or regional 
head/neck cancer failures following platinum-based 
concurrent chemoradiotherapy is feasible and can 
provide the opportunity for disease control and 
survival.  Post-operative complication rates, timing 
and patterns of disease failure, locoregional con-
trol, freedom from disease failure, and overall sur-
vival rates are similar to those described in series 
of surgically salvaged patients treated with prior ra-
diotherapy alone or sequential chemotherapy and 
radiation.  
13.  Yom SS, Machtay M, Biel MA, et al. Survival impact of 
planned restaging and early surgical salvage following de-
finitive chemoradiation for locally advanced squamous cell 
carcinomas of the oropharynx and hypopharynx. Am J Clin 
Oncol 2005; 28:385-392.
14.  Cognetti DM, Weber RS, Lai SY. Head and neck cancer: 
an evolving treatment paradigm. Cancer 2008; 113(7 sup-
pl):1911-1932.
15.  Agra IMG, Carvalho, AL, Ulbrich FS, et al. Prognostic fac-
tors in salvage surgery for recurrent oral and oropharyn-
geal cancer. Head Neck 2006; 28:107-113.
16.  Withrow KP, Rosenthal EL, Gourin CG, et al. Free tissue 
transfer to manage salvage laryngectomy defects after 
organ preservation failure. Laryngoscope 2007; 117:781-
784.  
17.  Ganly I, Patel SG, Matsuo J, et al. Results of surgical sal-
vage after failure of definitive radiation therapy for early-
stage squamous cell carcinoma of the glottic larynx. Arch 
Otolaryngol Head Neck Surg 2006; 132:59-66.
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